Substance Use Harm Reduction and Medication-Assisted Treatment

Registration


The cost for this online course is $20. The estimated time to complete this course is 60 minutes. Learners will be asked to complete an activity post-assessment with a passing score of 75%.

You must log in or create an account before enrolling in this educational activity. 

Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage.
 

Target Audience

Healthcare professionals.

Objectives

  1. Distinguish between Opioid Use Disorder and Harm Reduction with Medicated Assisted Treatment (MAT).
  2. Address stigma by the public and health providers.
  3. Describe the medications used in MAT.
  4. Recognize the importance of psychosocial support in treating the “whole” person with Substance Use Disorders.
  5. Review techniques for managing patients who are on MAT in various medical settings (Primary Care, Hospitalized, OTP) and the application of Harm Reduction techniques.

Educational Need

Drug overdose deaths have risen in the United States over the past two decades. Key findings from the National Vital Statistics System found that: 

  • In 2021, 106,699 drug overdose deaths occurred, resulting in an age-adjusted rate of 32.4 per 100,000 standard population in the United States.
  • Adults aged 65 and over had the largest percentage increase in rates from 2020 through 2021.
  • Drug overdose death rates increased for each race and Hispanic-origin group except non-Hispanic Asian people between 2020 and 2021.
  • The rate of drug overdose deaths involving synthetic opioids other than methadone increased by 22%, while deaths involving heroin declined by 32% between 2020 and 2021.
  • From 2020 through 2021, the rate of drug overdose deaths increased for deaths involving cocaine and those involving psychostimulants with abuse potential.

National Center for Health Statistics 2022. DOI: https://dx.doi.org/10.15620/cdc:122556.

Speakers

Heather Rice
Person in Recovery

Frank Filippelli, DO, PhD
Medical Director, UCS Healthcare 

Terms of Use and Privacy Policy

Recording date: October 5, 2023
Date of original release: October 5, 2023
Most recent review/update: October 5, 2023
Termination date: October 4, 2025

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credits™
  • 1.00 AOA Category 1­B
  • 1.00 CE Contact Hour(s)
  • 1.00 CPME
  • 1.00 IBON
Course opens: 
10/05/2023
Course expires: 
10/04/2025
Cost:
$20.00

Accreditation Statements

  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 1-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • DPM: Des Moines University (DMU) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. DMU has approved this activity for a maximum of 1.0 continuing education contact hours.
  • Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.​
  • Other Healthcare Professionals: This enduring materials activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

Educational Grants

No ineligible company provided financial support for this continuing education activity. 

DISCLOSURE

The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director. 

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

  • Frank Filippelli, DO, PhD - Speaker
  • Heather Rice - Speaker

Disclaimer

The information provided in this activity is for continuing education purposes only. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Available Credit

  • 1.00 AMA PRA Category 1 Credits™
  • 1.00 AOA Category 1­B
  • 1.00 CE Contact Hour(s)
  • 1.00 CPME
  • 1.00 IBON

Price

Cost:
$20.00
Please login or Create an Account to take this course.